Screener
Merck & Co. MRK Allowance for Doubtful Accounts Receivable (Current)
Allowance for Doubtful Accounts Receivable (Current) at other companies
Other financials
Where this comes from
Reported directly by Merck & Co. in its filing.
Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.
The source filing: Merck & Co.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:11 PM EDT
- Fiscal quarter
- Q3 FY2028
- Calendar quarter
- Q3 2028
- Accession
- 0000310158-26-000212
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Current Assets | ||
| Cash and cash equivalents | $6,849 | $14,565 |
| Short-term investments | 292 | — |
| Accounts receivable (net of allowance for doubtful accounts of $108 in 2026 and $97 in 2025) | 12,564 | 11,775 |
| Inventories (excludes inventories of $6,381 in 2026 and $5,681 in 2025classified in Other assets - see Note 6) | 6,207 | 6,658 |
| Other current assets | 10,767 | 10,518 |
| Total current assets | 36,679 | 43,516 |
| Investments | 1,222 | 956 |
Item 1. Financial Statements
FAQ
- What is Merck & Co.'s allowance for doubtful accounts receivable (current)?
- Merck & Co. (MRK) reported allowance for doubtful accounts receivable (current) of $108M in Q2 2026.
- How has Merck & Co.'s allowance for doubtful accounts receivable (current) changed year-over-year?
- Merck & Co.'s allowance for doubtful accounts receivable (current) increased by 14.9% year-over-year, from $94M to $108M.
- What is the long-term trend for Merck & Co.'s allowance for doubtful accounts receivable (current)?
- Over 5 years (2020 to 2025), Merck & Co.'s allowance for doubtful accounts receivable (current) has grown at a 7.7% compound annual growth rate (CAGR), from $67M to $97M.
- What does allowance for doubtful accounts receivable (current) mean?
- This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.
Ask your AI about Merck & Co.'s allowance for doubtful accounts receivable (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude